Blood test kit

Information

  • Patent Grant
  • D800332
  • Patent Number
    D800,332
  • Date Filed
    Tuesday, September 23, 2014
    10 years ago
  • Date Issued
    Tuesday, October 17, 2017
    7 years ago
  • US Classifications
    Field of Search
    • US
    • D24 121
    • D24 216
    • D24 222-232
    • D10 78
    • D10 81
    • D10 103
    • 422 408000
    • 422 430000
    • 422 501-504
    • 422 068100
    • 422 547000
    • 422 067000
    • 422 411000
    • 422 401000
    • 422 420000
    • 436 163000
    • 436 164000
    • 436 169000
    • 435 006160
    • 435 091100
    • 435 006110
    • 435 287100
    • 435 287200
    • 435 007100
    • 435 007900
    • 600 300000
    • 600 583-584
    • 356 440000
    • 356 445000
    • CPC
    • B01J19/0046
    • G01N31/221
    • G01N31/22
    • G01N21/8483
    • G01N21/6428
    • G01N21/07
    • G01N21/774
    • G01N33/54366
    • G01N21/474
    • G01N33/76
    • G01N21/278
    • G01N33/558
    • B01L2400/0406
    • B01L9/54
    • B01L2300/0816
    • B01L3/502707
    • B01L3/5025
    • B01L3/5023
  • International Classifications
    • 2401
    • Term of Grant
      14Years
      Disclaimer
      This patent is subject to a terminal disclaimer.
Abstract
Description


FIG. 1 is a front perspective view of a blood test kit showing the new design.



FIG. 2 is a top plan view thereof.



FIG. 3 is a bottom plan view thereof.



FIG. 4 is a left side view thereof.



FIG. 5 is a right side view thereof.



FIG. 6 is a front end side view thereof; and,



FIG. 7 is a back end side view thereof.


The broken lines seen on the top of the blood test kit are included for the purpose of illustrating portions of the blood test kit that form no part of the claimed design. The broken lines seen on the bottom of the blood test kit are included for the purpose of illustrating a boundary of an unclaimed area of the blood test kit that forms no part of the claimed design.


Claims
  • The ornamental design for a blood test kit, as shown and described.
US Referenced Citations (28)
Number Name Date Kind
5728587 Kang Mar 1998 A
5939331 Burd Aug 1999 A
6239445 Shaeef May 2001 B1
6267722 Anderson Jul 2001 B1
D454398 Robertson Mar 2002 S
D456082 Bouse Apr 2002 S
D467348 McMichael Dec 2002 S
D468437 McMenamy Jan 2003 S
D495805 Lea Sep 2004 S
D500142 Crisanti Dec 2004 S
6855561 Jerome Feb 2005 B2
D512512 Bell Dec 2005 S
D531321 Godfrey Oct 2006 S
7285425 Shareef Oct 2007 B2
D561344 Kozak Feb 2008 S
7326578 Bateman Feb 2008 B2
D602599 Xiaowei Oct 2009 S
7847946 Krauth Dec 2010 B2
D639977 Francis Jun 2011 S
D640389 Francis Jun 2011 S
D655424 Castanon Mar 2012 S
D660977 Wagner May 2012 S
D660978 Wagner May 2012 S
8268636 Nazareth Sep 2012 B2
D668350 Rowley Oct 2012 S
D668779 Khan Oct 2012 S
8278109 Nazareth Oct 2012 B2
D676570 Chance Feb 2013 S
Non-Patent Literature Citations (3)
Entry
Sanada, et al.; “IL-33 and ST2 Comprise a Critical Biomechanically Induced and Cardioprotective Signaling System”; The Journal of Clinical Investigation; May 10, 2007.
Sanchez-Mas, et al.; “Modulcation of IL-33/ST2 System in Postinfraction Heart Failure: correlation with Cardiac Remodeling Markers”; European Journal of Clinical Investigation; vol. 44; 2014; pp. 643-651.
Seki, et al.; “Interleukin-33 Prevents Apoptosis and Improves survival After Experimental Myocardial Infarction Through ST2 Signaling”; American Heart Association; Feb. 16, 2010.